词条 | Draft:Chandrabhan Rao |
释义 |
Dr. Chandrabhan Rao LinkedIn Link: https://www.linkedin.com/in/dr-chandrabhan-rao-45648621/detail/recent-activity/ Dr. Chandrabhan Rao Facebook Link:https://www.facebook.com/chandrabhan.rao Principal Scientist & Consultant(FDA/CDSCO) for Biologics, Pharma& Food Ind. in Clinical Trials & Laboratory Set-up, New Delhi, Delhi, India Professional with Ph.D. in Microbiology (Bacteriology) from All IndiaInstitute of Medical Sciences(AIIMS), New Delhi; over more than 11 years of research experience across Bacteriology, Microbiology/Molecular Biology/Biomedical Sciences ExperienceCell culture based Cancer vaccine Principal ScientistMarch 2015 - PresentNoida Area, India Working on Cell culture based Cancer vaccine Free LancerConsultant (FDA/CDSCO) for Biologicals & Pharma in Preclinical/Clinical Trials, Clean Room Set-up March 2015 - PresentNew Delhi Area, India Consultant (FDA/CDSCO) for Biologicals, Pharma & Food Industry pre-clinical/ Clinical Trials, Clean Room & Laboratory Set-up, Preparation of Research, Preclinical and Clinical Trial project etc. AIIMS Research ScholarJuly 2007 - May 2016 (8 years 11 months) All India Institute of Medical Sciences, New Delhi EducationAll India Institute of Medical SciencesDoctor of Philosophy - Ph.D., Medical Microbiology and Bacteriology · (2009 - 2016) Indian Institute of Technology, Kanpur GATE (Life Sciences)- 2007, Life Sciences Bundelkhand University, Jhansi Master of Science - MS, Biomedical Sciences, General · (2004 - 2006) Deendayal Upadhyay Gorakhpur University Bachelor of Science - BS, Chemistry, Botany and Zoology · (2000 - 2003) SummaryDr. Chandrabhan Rao has completed Ph.D. in Microbiology from one of the premier institute of medical science i.e. All India Institute of Medical Sciences (AIIMS), New Delhi, India in 2016. His doctoral research work was based on “Analysis of Putative Virulence Factors and Molecular Typing of Clinical Isolates of Vancomycin and High-Level Gentamicin Resistant Enterococcus faecium and Enterococcus faecalis”. Their team first to identify the pandemic high-risk Clonal Complex CC17 (ST80 and ST17) of Enterococcus faecium and CC2 (ST181) and CC87 (ST28) MDR Enterococcus faecalis causing various severe infections in Indian tertiary care Hospital using the advanced genotypic techniques like PFGE & Sequencing. Currently, he is working as a Chief Scientific Officer for Manufacturing, Quality Control and Quality Assurance of "A customized Cell Therapy for treatment of Cancers" in Delhi, India, and his job responsibility Involves- Establish and perform testing protocols and provide scientific support Responsible for operating, manage & maintenance of established cGMP manufacturing Cell Culture Lab within cGMP guidelines Characterizing product performance through various scientific assays Assist with quality control testing & controlled document maintenance Prepare & follow appropriate SOPs Experience with data analysis and presenting data in a meaningful manner Management of supply chain, logistics, warehousing and transportation Regulatory documentation, approval & licensing process of biologics via FDA He has more than 11 years of research experience in the Indian Council of Medical Research (ICMR) and Department of Biotechnology (DBT) projects in Medical Microbiology/ Biomedical Sciences from India. My core area of research in various microbiological techniques- like Microbial Culture, Animal Cell Culture, Microscopic, antibiotic susceptibility testing, and molecular biology techniques- like PCR, PFGE, MLST/Sequencing, cloning, genetic data analysis; he is expertise in the handling of Mycobacterium tuberculosis in the BSL III Biosafety Laboratory. He has handling experience of Bioinformatics-fingerprinting and sequencing software/SPSS software etc. He has experience of design and establish a new laboratory, and managing the supply chain, logistics, warehousing, and transportation. References1. Dissemination of methicillin-resistant Staphylococcus aureus SCCmec type IV and SCCmec type V epidemic clones in a tertiary hospital: challenge to infection control. publication date Apr 2, 2014 publication description Epidemiol Infect 2. publication Decreased susceptibility to vancomycin in methicillin-resistant Staphylococcus aureus: a 5 year study in an Indian tertiary hospital publication title Decreased susceptibility to vancomycin in methicillin-resistant Staphylococcus aureus: a 5 year study in an Indian tertiary hospital. publication date Mar 2010 publication description Journal of Medical Microbiology |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。